Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 29.11.2021 | EN | Official Journal of the European Union | C 481/28 |

---

Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLITE)

(Case T-637/20) [(1)](#ntr1-C_2021481EN.01002801-E0001)

(EU trade mark - Invalidity proceedings - EU word mark JUVÉDERM VOLITE - Late payment of the appeal fee - Inadmissibility of the appeal before the Board of Appeal - Article 101(4) of Regulation (EU) 2017/1001 - Article 106(1)(b) of Regulation 2017/1001 - Restitutio in integrum)

(2021/C 481/40)

Language of the case: English

Parties

Applicant: Dermavita Company S.a.r.l. (Beirut, Lebanon) (represented by: D. Todorov, lawyer)

Defendant: European Union Intellectual Property Office (represented by: E. Markakis and V. Ruzek, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: Allergan Holdings France SAS (Courbevoie, France)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 21 August 2020 (Case R 1015/2020-4), relating to invalidity proceedings between Dermavita Company and Allergan Holdings France.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Dermavita Company S.a.r.l. to pay the costs. |

---

---

[Top](#document1)